Lawrence X. Yu

14.7k total citations · 4 hit papers
123 papers, 10.5k citations indexed

About

Lawrence X. Yu is a scholar working on Pharmaceutical Science, Pediatrics, Perinatology and Child Health and Statistics and Probability. According to data from OpenAlex, Lawrence X. Yu has authored 123 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pharmaceutical Science, 25 papers in Pediatrics, Perinatology and Child Health and 20 papers in Statistics and Probability. Recurrent topics in Lawrence X. Yu's work include Drug Solubulity and Delivery Systems (42 papers), Statistical Methods in Clinical Trials (20 papers) and Pharmaceutical studies and practices (20 papers). Lawrence X. Yu is often cited by papers focused on Drug Solubulity and Delivery Systems (42 papers), Statistical Methods in Clinical Trials (20 papers) and Pharmaceutical studies and practices (20 papers). Lawrence X. Yu collaborates with scholars based in United States, Thailand and China. Lawrence X. Yu's co-authors include Gordon L. Amidon, Janet Woodcock, Robert Lionberger, James E. Polli, Dale P. Conner, Mansoor A. Khan, Andre Raw, Barbara M. Davit, Sau L. Lee and Ajaz Hussain and has published in prestigious journals such as New England Journal of Medicine, Nature Biotechnology and Water Research.

In The Last Decade

Lawrence X. Yu

122 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Understanding Pharmaceutical Quality by Design

2014 918 citations Lawrence X. Yu, Mansoor A. Khan et al. The AAPS Journal profile →
Pharmaceutical Quality by Design: Product and Process Development, Understanding, and Control

2008 895 citations Lawrence X. Yu Pharmaceutical Research profile →
Modernizing Pharmaceutical Manufacturing: from Batch to Continuous Production

2015 642 citations Sau L. Lee, Lawrence X. Yu et al. profile →
Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future

2021 218 citations Nilou Arden, Adam C. Fisher et al. International Journal of Pharmaceutics profile →

Peers

Countries citing papers authored by Lawrence X. Yu

Since Specialization

Citations

This map shows the geographic impact of Lawrence X. Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence X. Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence X. Yu more than expected).

Fields of papers citing papers by Lawrence X. Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence X. Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence X. Yu. The network helps show where Lawrence X. Yu may publish in the future.

Co-authorship network of co-authors of Lawrence X. Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence X. Yu. A scholar is included among the top collaborators of Lawrence X. Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence X. Yu. Lawrence X. Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of Antioxidants in Medicinal Products on Intestinal Drug Transporters 2024 ·Pharmaceutics ·(unknown), Jia Yang, (unknown), (unknown), Khondoker Alam, Andre Raw, Bhagwant Rege, Liang Zhao, (unknown), Lei Zhang, Lawrence X. Yu, Robert Lionberger, Kathleen M. Giacomini, Deanna L. Kroetz, Sook Wah Yee	4
2	Antioxidants had No Effects on the In-Vitro Permeability of BCS III Model Drug Substances 2024 ·Journal of Pharmaceutical Sciences ·(unknown), Bhagwant Rege, Andre Raw, Jingyue Yang, Khondoker Alam, (unknown), Liang Zhao, Patrick J. Faustino, Fang Wu, Diaá M. Shakleya, (unknown), Bing V. Li, (unknown), (unknown), (unknown), (unknown), Ashley B. Boam, Robert Lionberger, David A. Keire, Lawrence X. Yu	2
3	Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future breakdown → 2021 ·International Journal of Pharmaceutics ·Nilou Arden, Adam C. Fisher, Katherine M. Tyner, Lawrence X. Yu, Sau L. Lee, (unknown)	218
4	The future of pharmaceutical quality and the path to get there 2017 ·International Journal of Pharmaceutics ·Lawrence X. Yu, (unknown)	112
5	FDA pharmaceutical quality oversight 2015 ·International Journal of Pharmaceutics ·Lawrence X. Yu, Janet Woodcock	33
6	International Guidelines for Bioequivalence of Systemically Available Orally Administered Generic Drug Products: A Survey of Similarities and Differences 2013 ·The AAPS Journal ·Barbara M. Davit, (unknown), Dale P. Conner, Lawrence X. Yu	86
7	Impact of Osmotically Active Excipients on Bioavailability and Bioequivalence of BCS Class III Drugs 2013 ·The AAPS Journal ·Mei‐Ling Chen, Nakissa Sadrieh, Lawrence X. Yu	37
8	Preclinical Pharmacokinetics of MI-219, a Novel Human Double Minute 2 (HDM2) Inhibitor and Prediction of Human Pharmacokinetics 2012 ·Journal of Pharmacy & Pharmaceutical Sciences ·Peng Zou, Nan Zheng, Yanke Yu, Shanghai Yu, Wei Sun, (unknown), Yongsheng Yang, Lawrence X. Yu, Shaomeng Wang, Duxin Sun	12
9	Prediction of volume of distribution at steady state in humans: comparison of different approaches 2012 ·Expert Opinion on Drug Metabolism & Toxicology ·Peng Zou, Nan Zheng, Yongsheng Yang, Lawrence X. Yu, Duxin Sun	26
10	Statistics on BCS Classification of Generic Drug Products Approved Between 2000 and 2011 in the USA 2012 ·The AAPS Journal ·Anil K. Nair, Om Anand, (unknown), Dale P. Conner, Mehul U. Mehta, (unknown), James E. Polli, Lawrence X. Yu, Barbara M. Davit	17
11	The BCS, BDDCS, and Regulatory Guidances 2011 ·Pharmaceutical Research ·Mei-Ling Chen, Gordon L. Amidon, Leslie Z. Benet, Hans Lennernäs, Lawrence X. Yu	62
12	Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis 2011 ·International Journal of Pharmaceutics ·Ahmed S. Zidan, Ziyaur Rahman, Vilayat A. Sayeed, Andre Raw, Lawrence X. Yu, Mansoor A. Khan	90
13	Harmonization of Regulatory Approaches for Evaluating Therapeutic Equivalence and Interchangeability of Multisource Drug Products: Workshop Summary Report 2011 ·The AAPS Journal ·Mei‐Ling Chen, Vinod P. Shah, Daan J.A. Crommelin, Leon Shargel, (unknown), (unknown), Henning Blume, Jennifer Dressman, Murray P. Ducharme, Paul Fackler, Terry Hyslop, (unknown), José Morais, Eric Ormsby, (unknown), (unknown), Raja Velagapudi, Lawrence X. Yu	13
14	Generic omeprazole delayed-release capsules: in vitro performance evaluations 2009 ·Drug Development and Industrial Pharmacy ·Terry W. Moore, (unknown), Wei Ye, (unknown), Benjamin J. Westenberger, Robert Lionberger, Andre Raw, Lawrence X. Yu, Lucinda F. Buhse	9
15	Mechanistic Approaches to Predicting Oral Drug Absorption 2009 ·The AAPS Journal ·Weili Huang, Sau Lawrence Lee, Lawrence X. Yu	122
16	The Use of BDDCS in Classifying the Permeability of Marketed Drugs 2008 ·Pharmaceutical Research ·Leslie Z. Benet, Gordon L. Amidon, D.M. Barends, Hans Lennernäs, James E. Polli, Vinod P. Shah, Salomon Stavchansky, Lawrence X. Yu	100
17	Evaluation of a Scaling Approach for the Bioequivalence of Highly Variable Drugs 2008 ·The AAPS Journal ·Sam Haidar, Fairouz Makhlouf, Donald J. Schuirmann, Terry Hyslop, Barbara M. Davit, Dale P. Conner, Lawrence X. Yu	70
18	Validation and application of a stability-indicating HPLC method for the in vitro determination of gastric and intestinal stability of venlafaxine 2007 ·Journal of Pharmaceutical and Biomedical Analysis ·Ebenezer B. Asafu-Adjaye, Patrick J. Faustino, Mobin A. Tawakkul, Lawrence W. Anderson, Lawrence X. Yu, (unknown), Donna A. Volpe	49
19	Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs 2003 ·International Journal of Pharmaceutics ·Lawrence X. Yu, (unknown), Gordon L. Amidon, Ajaz S. Hussain	159
20	Predicting Human Oral Bioavailability of a Compound: Development of a Novel Quantitative Structure-Bioavailability Relationship 2000 ·Pharmaceutical Research ·C. Webster Andrews, L. Michelle Bennett, Lawrence X. Yu	98

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact